Umarje Siddhi, James Neha M, Dave Priti, Raut Asawari, Pandey Neha
Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.
Department of Medicine, Bharati Vidyapeeth Medical College, Bharati Vidyapeeth (Deemed to be) University, Pune, Maharashtra, India.
Indian J Endocrinol Metab. 2021 May-Jun;25(3):206-210. doi: 10.4103/ijem.ijem_120_21. Epub 2021 Oct 26.
Cardiovascular diseases and its risk factors, such as diabetes and hyperlipidemia, are common in Indian population. Statin utilization is high across the country and it is important to assess the adherence because it plays an important role in treatment outcome. Statin adherence is not studied well in India. This study aims at measuring the adherence, perception, and knowledge of individuals on statin therapy.
Cross-sectional observational study on 130 consented individuals visiting a tertiary care teaching hospital. Study was conducted for a duration of 9 months.
After obtaining approval from the institutional ethics committee the study subjects were assessed for knowledge, perception, and adherence to statin therapy using a systematically developed interview questionnaire.
Good adherence was seen in 42.30% patients. Higher proportions of females were reported to have good adherence. Good adherence was observed in patients with a history of coronary heart disease and atorvastatin as monotherapy ( = 0.0029) and fixed dose combination ( = 0.0012), whereas lipid reduction was found directly related to type of adherence. Lack of knowledge, cost, re-fill issues, and adverse effects were some of the barriers identified.
Knowledge and patient perception plays a very important role in determining the adherence to statin therapy. A history of coronary heart disease, choice of statin, and cost of therapy are the contributing factors to adherence. Patient counselling and improving the cost-effectiveness of statin therapy can be considered as interventional strategies to overcome adherence issues.
心血管疾病及其危险因素,如糖尿病和高脂血症,在印度人群中很常见。他汀类药物在该国的使用率很高,评估其依从性很重要,因为它在治疗结果中起着重要作用。在印度,他汀类药物的依从性研究较少。本研究旨在衡量个体对他汀类药物治疗的依从性、认知和知识水平。
对130名同意参与的前往三级护理教学医院就诊的个体进行横断面观察研究。研究持续了9个月。
在获得机构伦理委员会批准后,使用系统开发的访谈问卷对研究对象的他汀类药物治疗知识、认知和依从性进行评估。
42.30%的患者依从性良好。据报告,女性依从性良好的比例更高。冠心病病史患者以及使用阿托伐他汀单药治疗(P = 0.0029)和固定剂量联合治疗(P = 0.0012)的患者依从性良好,而降脂效果与依从性类型直接相关。发现缺乏知识、费用、重新配药问题和不良反应是一些确定的障碍。
知识和患者认知在决定他汀类药物治疗的依从性方面起着非常重要的作用。冠心病病史、他汀类药物的选择和治疗费用是影响依从性的因素。患者咨询和提高他汀类药物治疗的成本效益可被视为克服依从性问题的干预策略。